 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H16N2O |
| Molar mass | 264.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Methylmethaqualone (MMQ) is aquinazolinone and an analogue ofmethaqualone that has similarsedative andhypnotic properties to its parent compound (resulting from its agonist activity at the β subtype of theGABAA receptor) and is around 3 times as potent in animal models.[1] Methylmethaqualone differs from methaqualone by 4-methylation on the phenyl ring. It was made illegal in Germany in 1999 and listed by theDEA as a "drug of forensic interest" at about the same time, but little other information is available. It would appear that this compound was sold on the black market in Germany as adesigner druganalogue of methaqualone.[2][3]
Animal studies of methylmethaqualone have shown it to produceconvulsions at only slightly above the effective sedative dose,[4] and anecdotal reports from human users have confirmed that it can have a pro-convulsive effect, which has potential to make this compound particularly hazardous if taken in excessive doses.
